P

PTC Therapeutics
D

PTCT

45.100
USD
-0.15
(-0.33%)
مغلق
حجم التداول
32,269
الربح لكل سهم
3
العائد الربحي
-
P/E
-8
حجم السوق
3,478,343,949
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABUS
    0.02000
    (0.63%)
    3.22000 USD
    A
    ARCT
    0.260
    (1.58%)
    16.680 USD
    A
    ARWR
    -0.050
    (-0.25%)
    19.710 USD
    C
    CRNX
    -0.120
    (-0.31%)
    38.700 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    G
    GLPG
    0.075
    (0.31%)
    23.920 USD
    R
    RARE
    1.650
    (4.00%)
    42.950 USD
    S
    SLDB
    -0.13000
    (-3.99%)
    3.13000 USD
    S
    SRPT
    -0.920
    (-0.79%)
    116.020 USD
    V
    VKTX
    1.170
    (3.56%)
    34.060 USD
    V
    VYGR
    0.22000
    (4.21%)
    5.45000 USD
    المزيد
الأخبار
المقالات

العنوان: PTC Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.